《公司業績》謝瑞麟(00417.HK)全年虧轉盈賺1,554.6萬元 派末期息2仙
謝瑞麟(00417.HK)公布截至今年3月底止全年業績,營業額27.68億元,按年升4.5%。虧轉盈賺1,554.6萬元,上年同期蝕4,398萬元;每股盈利6.2仙。派末期息2仙,上年同期不派息。
年內受惠於零售市場復甦,集團香港及澳門零售業務的營業額按年上升,同店銷售亦錄得增長。集團策略性地關閉了兩間位於旺角及尖沙咀的低效店舖,截至今年3月底止,香港店舖總數為24間。
至於集團在內地營運的同店銷售則有輕微負增長。於本年度,集團在內地的店舖總數由450間增加至465間,包括自營店和加盟店。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.